Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 11 studies | 27% ± 10% | |
type I pneumocyte | 10 studies | 28% ± 6% | |
club cell | 8 studies | 25% ± 7% | |
epithelial cell | 7 studies | 37% ± 17% | |
basal cell | 6 studies | 31% ± 17% | |
respiratory goblet cell | 5 studies | 25% ± 6% | |
goblet cell | 5 studies | 24% ± 13% | |
secretory cell | 3 studies | 30% ± 6% | |
squamous epithelial cell | 3 studies | 43% ± 19% | |
enterocyte | 3 studies | 20% ± 4% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 20% ± 2% | |
abnormal cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 4972.82 | 180 / 180 | 99% | 82.12 | 426 / 430 |
prostate | 100% | 12900.99 | 245 / 245 | 99% | 92.21 | 496 / 502 |
bladder | 100% | 7589.05 | 21 / 21 | 98% | 167.77 | 492 / 504 |
intestine | 100% | 8480.33 | 964 / 966 | 98% | 142.73 | 514 / 527 |
esophagus | 100% | 10510.54 | 1444 / 1445 | 97% | 236.18 | 178 / 183 |
stomach | 100% | 6103.02 | 358 / 359 | 96% | 132.22 | 275 / 286 |
uterus | 100% | 6118.09 | 170 / 170 | 95% | 159.08 | 437 / 459 |
lung | 99% | 6716.13 | 571 / 578 | 96% | 106.41 | 1113 / 1155 |
kidney | 100% | 13687.87 | 89 / 89 | 91% | 57.13 | 822 / 901 |
pancreas | 97% | 4627.30 | 317 / 328 | 94% | 99.70 | 168 / 178 |
thymus | 100% | 13519.34 | 653 / 653 | 90% | 93.71 | 545 / 605 |
breast | 83% | 7559.69 | 381 / 459 | 98% | 291.60 | 1100 / 1118 |
skin | 100% | 14704.26 | 1809 / 1809 | 65% | 20.63 | 306 / 472 |
liver | 73% | 3064.69 | 164 / 226 | 60% | 26.11 | 242 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 108.49 | 1 / 1 |
blood vessel | 100% | 9158.16 | 1332 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 133.85 | 44 / 45 |
heart | 95% | 7029.52 | 815 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 18.80 | 60 / 80 |
adipose | 74% | 2321.70 | 886 / 1204 | 0% | 0 | 0 / 0 |
muscle | 71% | 1972.47 | 569 / 803 | 0% | 0 | 0 / 0 |
brain | 32% | 936.16 | 856 / 2642 | 29% | 9.23 | 205 / 705 |
spleen | 29% | 678.59 | 71 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 9% | 225.59 | 24 / 258 | 2% | 0.34 | 4 / 230 |
peripheral blood | 2% | 48.36 | 18 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0038133 | Biological process | ERBB2-ERBB3 signaling pathway |
GO_0032886 | Biological process | regulation of microtubule-based process |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0042552 | Biological process | myelination |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0007507 | Biological process | heart development |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0007167 | Biological process | enzyme-linked receptor protein signaling pathway |
GO_0007275 | Biological process | multicellular organism development |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0045765 | Biological process | regulation of angiogenesis |
GO_0042060 | Biological process | wound healing |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0030182 | Biological process | neuron differentiation |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0022008 | Biological process | neurogenesis |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0014044 | Biological process | Schwann cell development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0038134 | Biological process | ERBB2-EGFR signaling pathway |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0090314 | Biological process | positive regulation of protein targeting to membrane |
GO_0045727 | Biological process | positive regulation of translation |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0008045 | Biological process | motor neuron axon guidance |
GO_0033088 | Biological process | negative regulation of immature T cell proliferation in thymus |
GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
GO_0038135 | Biological process | ERBB2-ERBB4 signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0099645 | Biological process | neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0033080 | Biological process | immature T cell proliferation in thymus |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0032587 | Cellular component | ruffle membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0002116 | Cellular component | semaphorin receptor complex |
GO_0043235 | Cellular component | receptor complex |
GO_0043209 | Cellular component | myelin sheath |
GO_0005886 | Cellular component | plasma membrane |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0038143 | Cellular component | ERBB3:ERBB2 complex |
GO_0005829 | Cellular component | cytosol |
GO_0010008 | Cellular component | endosome membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0015026 | Molecular function | coreceptor activity |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0001042 | Molecular function | RNA polymerase I core binding |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0043125 | Molecular function | ErbB-3 class receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | ERBB2 |
Protein name | Erb-b2 receptor tyrosine kinase 2 Receptor protein-tyrosine kinase (EC 2.7.10.1) Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340) receptor protein-tyrosine kinase (EC 2.7.10.1) Receptor tyrosine-protein kinase erbB-2 (Proto-oncogene c-ErbB-2) (p185erbB2) Alternative protein ERBB2 V-erb-b2 avian erythroblastic leukemia viral oncoprotein 2 isoform C Receptor tyrosine-protein kinase erbB-2 variant (EC 2.7.10.1) ERBB2 Truncated HER2 splice variant p100 Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Proto-oncogene c-ErbB-2) (p185erbB2) |
Synonyms | NGL NEU hCG_28177 HER-2 HER2 MLN19 |
Description | FUNCTION: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. .; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. . FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. . FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. . FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. . |
Accessions | ENST00000584450.5 Q9NP09 Q4H1F2 J3QRJ7 Q4H1F1 ENST00000580074.1 ENST00000582648.5 ENST00000584601.5 [P04626-5] X5DNK3 ENST00000541774.5 [P04626-4] J3QLV2 J3QL83 ENST00000269571.10 [P04626-1] J3QRX1 L8E8G2 ENST00000406381.6 [P04626-5] ENST00000582818.5 J3KTI5 Q9UK79 P04626 ENST00000578709.5 ENST00000578199.5 J3QLU9 E2I6F8 F5H1T4 ENST00000445658.6 X5DQX2 A0A7T8JKQ4 B4DTR1 ENST00000578502.1 J3KRI9 ENST00000578373.5 A0A0R9RWK2 |